Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Alzheimer's Disease
Dementia
Dementia with Lewy Bodies
Frontotemporal Dementia
Vascular Dementia
Mild Cognitive Impairment
View all Diseases
Topics
Diagnostics
Biology
Communication
Treatment
Care Practice
Prevention
View all Topics
Conferences
AAN 2022
CONy 2022
AD/PD 2022
ARUK 2022
AAIC 2021
ARUK 2021
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Treatment
4:52
Important developments in dementia: biomarkers & clinical trials
Philip Tipton
• 3 Apr 2022
3:11
Targeting β-amyloid and tau in Alzheimer’s disease
Philip Tipton
• 3 Apr 2022
1:53
Including people with Down’s syndrome in Alzheimer’s disease research
Johannes Levin
• 21 Mar 2022
3:56
The current state of gene editing in treating Alzheimer’s disease
George Perry
• 22 Mar 2022
8:03
Non-pharmacological interventions to prevent dementia progression
Magda Tsolaki
• 16 Mar 2022
3:28
Implications of heterogeneity in Alzheimer’s disease
George Perry
• 22 Mar 2022
5:16
The role of β-amyloid in AD: still a central characteristic?
Magda Tsolaki
• 16 Mar 2022
2:55
Limitations in understanding Alzheimer’s disease for gene editing
George Perry
• 22 Mar 2022
2:00
Early diagnosis & genetic risk in Alzheimer’s disease
Magda Tsolaki
• 16 Mar 2022
1:41
Mechanisms influencing mitochondrial dysfunction in Alzheimer’s disease
Mounia Chami
• 18 Mar 2022
1:36
Immunotherapy in treating Alzheimer’s disease
Beka Solomon
• 17 Mar 2022
4:42
Inhibition of CXCR4/CXCL12 signaling: a translational perspective for Alzheimer’s disease treatment
Beka Solomon
• 17 Mar 2022
2:32
Increasing the expression of Mer receptors in microglia: a potential therapy for Alzheimer’s disease
Greg Lemke
• 18 Mar 2022
1:12
Targeting the AMPK cascade to rescue mitochondrial dysfunctions in Alzheimer’s disease
Mounia Chami
• 18 Mar 2022
0:38
Antibody-based therapy in Alzheimer’s disease: future outlook
Greg Lemke
• 18 Mar 2022
4:01
Comparing binding characteristics to Aβ of lecanemab, aducanumab & gantenerumab
Lars Lannfelt
• 16 Mar 2022
1
2
3
4
5
…
7
Next